Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ISRCTN |
Last refreshed on:
|
8 January 2018 |
Main ID: |
ISRCTN49681405 |
Date of registration:
|
30/08/2012 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Evaluating femtosecond laser assisted cataract and lens surgery
|
Scientific title:
|
Prospective observational study to evaluate femtosecond laser lens fragmentation, anterior capsulotomy cataract and lens extraction surgery |
Date of first enrolment:
|
28/08/2012 |
Target sample size:
|
100 |
Recruitment status: |
Completed |
URL:
|
http://isrctn.com/ISRCTN49681405 |
Study type:
|
Observational |
Study design:
|
Prospective observational study (Treatment)
|
Phase:
|
|
|
Countries of recruitment
|
United Kingdom
| | | | | | | |
Contacts
|
Name:
|
|
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
|
|
Name:
|
Julian
Stevens |
Address:
|
81 Britannia Walk
N1 7RH
London
United Kingdom |
Telephone:
|
+44 20 7251 4835/4836 |
Email:
|
info@julianstevens.co.uk |
Affiliation:
|
|
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: Any subject planned to undergo femtosecond laser assisted lens surgery. These subjects will already meet these criteria: 1. Subjects must be adults (>16 years), undergoing refractive lens or cataract surgery 2. Subjects must provide informed consent, have signed the written informed consent form, and been given a copy 3. Subjects must have a calculated average corneal power after of = 50.00 D in the eye to be implanted 4. Subjects must have a pharmacologically dilated pupil >6.0 mm, in the eye to be implanted 5. The central anterior chamber depth must be >2.0 mm (Pentacam) 6. Subjects must be willing and able to return for scheduled follow up examinations for 3 months after surgery
Exclusion criteria: 1. Subjects with subluxated crystalline lens 2. Subjects with endothelial dystrophy, guttata, in the eye to be implanted 3. Subjects with keratoconus (or keratoconus suspect) in the eye to be implanted or K>50 D 4. Subjects with distorted or unclear corneal mires on topography maps of the eye to be implanted 5. Subjects with a history of Herpes zoster or Herpes simplex keratitis. 6. The central anterior chamber depth <2.0 mm (Pentacam) 7. Tremor with head titubation 8. Subjects who are participating in any other ophthalmic drug or device clinical trial during the time of this clinical investigation
Age minimum:
Age maximum:
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Cataract, refractive error Eye Diseases Other cataract
|
Intervention(s)
|
This is an observational study of surgery outcomes.
|
Primary Outcome(s)
|
To record any complications or adverse events
|
Secondary Outcome(s)
|
To describe the ability of the intraocular femtosecond laser to successfully perform an anterior capsulotomy and phakofragmentation during cataract/lens surgery.
|
Secondary ID(s)
|
Protocol version 4.3
|
Source(s) of Monetary Support
|
Investigator initiated and funded
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|